|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
«
5AM
Aper »
|
 |
|
|
5AM Ventures
Offices: Menlo Park, California & Waltham,
Massachusetts
5AM Ventures is a $65 million seed and early-stage
fund that is focused on creating and building
the next generation of leading biotechnology
companies. 5AM works with entrepreneurs
and scientists to help shape the strategic
mission of new start-ups (or spin-outs)
and provides business, financial, deal structuring,
recruiting and other assistance in the company-building
process. 5AM provides the initial stages
of capital, either alone or in a VC syndicate,
bringing companies to critical value-creating
milestones which enable subsequent financings
with established VC firms. |
7 Health Ventures
Offices: Edina, Minnesota
7 Health Ventures is a professional venture
capital fund dedicated to investing in Israeli
and Israeli-related companies, developing
healthcare technologies and products. Their
commitment to their entrepreneurs is for
a long-term partnership because they understand
that building a successful company takes
time. They accompany their entrepreneurs
with integrity, resourcefulness and dedication.
Their goal is to bring their ideas to life
by helping them turn their vision into breakthrough
technologies and robust products. |
20/20 HealthCare Partners
Offices: Auburndale, Massachusetts
At 20/20, they have assembled a group of
experts with a diverse range of backgrounds
who have developed a vision for healthcare
in the year 2020. This vision guides their
strategy for developing and commercializing
technologies that they feel will accelerate
the implementation of successful 'Personalized
Medicine' approaches. Their team approach
relies on an efficient and strategic use
of time and resources, to bring their portfolio
companies' products to market. |
|
|
Aberdare Ventures
Offices: San Francisco, California
The Aberdare Ventures team are experienced
venture investors and operators of healthcare
technology companies. Their investment focus
is driven by their years of experience growing
biopharmaceutical product companies and
therapeutic medical device companies. They
have plenty of experience leading early-stage
investments, but they are comfortable co-investing
as well. Aberdare is willing to participate
in financings as small as $1 million, but
also has the capacity to invest $4-7 million
in a company over time. |
Abingworth Management
Offices: Palo Alto, California; Boston,
Massachusetts & London, England
Abingworth is a long-established venture
capital firm specializing in unquoted and
life science biomedical companies. Abingworth
is active on both sides of the Atlantic
and, in the past fifteen years, has backed
more than 80 developing life science/medical
businesses. The majority of these have gone
on to public offerings or have merged or
been acquired by leading companies in the
industry. Abingworth has funds under management
of over $700 million. |
Acacia Venture Partners
Offices: San Francisco, California
Acacia Venture Partners specializes in solely
in identifying and building leading service
businesses in the healthcare industry. They
firmly believe that industry focus is critical
to creating long term value in healthcare.
Acacia's team of venture capital professionals
has been investing in healthcare since the
early 1980's. They have developed a deep
industry understanding and a robust network
of contact in the healthcare industry. |
Accuitive Medical Ventures (AMV)
Offices: Atlanta, Georgia; Newport Beach,
California & Rochester, Minnesota
Accuitive is a venture capital firm in business
to finance and help develop early and expansion
stage medical device and technology companies.
AMV has established relationships with some
of the industry's leading institutions to
offer emerging companies and investors the
opportunity to work with AMV in building
unique new businesses and long-term shareholder
value. In addition, AMV's connections to
some of the industry’s leading practitioners
and thought leaders across multiple specialties
enable them to add substantial value both
as an investor and Board member. |
Aescap
Offices: The Netherlands
Aescap Venture is a new Venture Capital
Company targeted at European biomedical
companies. Their added value is based on
best of breed investment managers. All with
a proven track record and the ability to
coach and stimulate entrepreneurs in the
creation and growth of their companies.
Their aim is to accelerate the creation
of value in the companies they invest in.
|
Affinity Capital Management
Offices: Minneapolis, Minnesota
Affinity Capital Management invests in private,
US-based health care companies. Within
health care, they focus on the medical device,
biotech, health care service and health
care information technology sectors.
They prefer companies with proprietary technology
that have the potential to achieve and sustain
leadership positions in large growing markets. |
Aisling Capital
Offices: New York, New York
Aisling Capital Believes the next decade
will be marked by a revolution in healthcare
driven by new therapeutics generated by
biotechnology. The completion of human genome
has given scientists new insights into the
cause of human disease. These insights,
combined with the past 20 years of developments
in the biotechnology industry, are leading
to rapid expansion of novel approaches toward
the diagnosis, prevention, and treatment
of life-threatening illnesses. |
| |
|
|
|
Bio
Life (-Aperion-)
Resources
to
top